<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report here on the preliminary treatment findings of a CCLSG NHL 960 study that was initiated in March 1996 </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, 37 patients with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were assigned to 4 different treatment groups according to disease stage and histology: (1) <z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e>; (2) advanced disease, lymphoblastic type; (3) advanced disease, large cell type; and (4) advanced disease, Burkitt type </plain></SENT>
<SENT sid="2" pm="."><plain>The first three groups received the modified protocols of the NHL 890 study </plain></SENT>
<SENT sid="3" pm="."><plain>Groups 1 and 3 received COPADM induction therapy (CPM, VCR, PRD, ADR, and MTX) </plain></SENT>
<SENT sid="4" pm="."><plain>After achieving remission, Group 1 received only maintenance therapy consisting of alternate administration of 7 drugs, while Group 3 received additional intensification therapy with combination chemotherapy consisting of MTX and Ara-C, followed by a maintenance phase involving the administration of 9 drugs </plain></SENT>
<SENT sid="5" pm="."><plain>Group 2 received COPADL induction therapy (CPM, VCR, PRD, ADR, and LASP) and consolidation/intensification therapies followed by a maintenance phase </plain></SENT>
<SENT sid="6" pm="."><plain>Group 4 received short-term intensive COPADM polychemotherapy </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve patients with localized with <z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e> (stage I-II) and 25 patients with advanced disease (stage III-IV) were enrolled in this study </plain></SENT>
<SENT sid="8" pm="."><plain>Except for 2 patients in the advanced disease stages who died earlier in the course of the study, <z:hpo ids='HP_0000001'>all</z:hpo> patients remained in remission </plain></SENT>
</text></document>